Lisa M. Cordes

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Papers

Driven by 66 papers — median percentile 0. Top paper: “Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2024)10.1056/nejmoa2401726

N/A

3.9DataRank · unranked

151 citations

Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh +35 more

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001395

N/A

3.6DataRank · unranked

159 citations

Margaret E. Gatti‐Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward F. McClay +18 more

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Journal of Clinical Oncology(2020)10.1200/jco.20.01652

N/A

3.5DataRank · unranked

138 citations

Rosa Nadal, Daniel M. Girardi, Scot A. Niglio, Lisa Ley, Lisa M. Cordes +30 more

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30202-3

N/A

3.0DataRank · unranked

89 citations

Rosa Nadal, Yusuke Tomita, Nicole N. Davarpanah, Lisa M. Cordes, Seth M. Steinberg +27 more

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000655

N/A

1.8DataRank · unranked

77 citations

Jennifer L. Marté, Renee N. Donahue, Beatriz Walter-Rodriguez, Christopher R. Heery, Seth M. Steinberg +13 more

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344

N/A

1.2DataRank · unranked

38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

Frontiers in Endocrinology(2020)10.3389/fendo.2020.00490

N/A

0.888DataRank · unranked

23 citations

Renee N. Donahue, Jennifer L. Marté, Ann W. Gramza, Marijo Bilušić, Myrna Rauckhorst +7 more

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide

The Oncologist(2022)10.1093/oncolo/oyac100

N/A

0.790DataRank · unranked

24 citations

Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Cindy H. Chau, Cody J. Peer +8 more

Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04134-9

N/A

0.730DataRank · unranked

20 citations

Alwin D. R. Huitema, Thomas P. C. Dorlo, Cody J. Peer, Lisa M. Cordes, Linda Sciuto +6 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0.593DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review

Cancer Treatment Reviews(2021)10.1016/j.ctrv.2021.102333

N/A

0.587DataRank · unranked

49 citations

Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo +1 more

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2891

N/A

0.584DataRank · unranked

48 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Avelumab in Patients With Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad162

N/A

0.332DataRank · unranked

6 citations

Geraldine O’Sullivan Coyne, Clay T. Reed, Ravi A. Madan, Julius Strauss, Seth J Steinberg +5 more

Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

Journal of Immunotherapy(2023)10.1097/cji.0000000000000459

N/A

0.261DataRank · unranked

4 citations

Jason M. Redman, Fatima Karzai, William L. Dahut, Lisa M. Cordes, Farhad Fakhrejahani +5 more

Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection

The Oncologist(2025)10.1093/oncolo/oyaf006

N/A

0.251DataRank · unranked

4 citations

Renee N. Donahue, Seth J Steinberg, Jennifer L. Marté, Lisa M. Cordes, Charalampos S. Floudas +7 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0.245DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0.241DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Phase II evaluation of combination immunotherapy with CV301, N-803, bintrafusp alfa, and M9241 in patients with advanced small bowel and colorectal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.116

N/A

0.241DataRank · unranked

4 citations

Jason M. Redman, Charalampos S. Floudas, Elizabeth Lamping, Deneise C Francis, Lisa M. Cordes +5 more

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5096

N/A

0.208DataRank · unranked

3 citations

Marijo Bilušić, Fatima Karzai, Lisa M. Cordes, Julius Strauss, Houssein Abdul Sater +10 more

Ipilimumab challenge/re-challenge in metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors treated with cabozantinib+nivolumab (CaboNivo) or cabozantinib+nivolumab+ipilimumab (CaboNivoIpi).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5039

N/A

0.208DataRank · unranked

3 citations

Daniel M. Girardi, Amir Mortazavi, Primo N. Lara, Sumanta K. Pal, Biren Saraiya +15 more

Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) with progressive disease following immune checkpoint inhibitor (ICI) therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5037

N/A

0.165DataRank · unranked

2 citations

Scot A. Niglio, Amir Mortazavi, Primo Lara, Sumanta K. Pal, Biren Saraiya +15 more

A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)—design and rationale

Future Oncology(2025)10.1080/14796694.2025.2480534

N/A

0.165DataRank · unranked

2 citations

Elias Chandran, Saad Atiq, Andre R. Kydd, Daniel M. Girardi, Lisa Ley +14 more

Patients with undetectable PSA 2 years after docetaxel for metastatic castration sensitive prostate cancer (mCSPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17044

N/A

0.104DataRank · unranked

1 citations

Shruti U. Gandhy, Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Helen Owens +8 more

PSMA PET findings in patients with undetectable PSA more than 3 years after docetaxel for metastatic castration-sensitive prostate cancer (mCSPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17046

N/A

0.104DataRank · unranked

1 citations

Shruti U. Gandhy, Fatima Karzai, Munjid Al Harthy, Gang Chen, Marijo Bilušić +15 more

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report

Frontiers in Oncology(2023)10.3389/fonc.2023.1126476

N/A

0.104DataRank · unranked

1 citations

Danielle M. Pastor, Fatima Karzai, Amy Hankin, Barış Türkbey, Lisa M. Cordes +5 more

A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4571

N/A

0.104DataRank · unranked

1 citations

Scot A. Niglio, Elias Chandran, Giovanni Maria Iannantuono, Salah Boudjadi, Rouf Banday +15 more

A pilot clinical trial of genomic-based therapy assignment with co-expression extrapolation (COXEN) in advanced/metastatic urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.452

N/A

0DataRank · unranked

0 citations

Rosa Maria Nadal, Lisa M. Cordes, Seth M. Steinberg, Nicole N. Davarpanah, Rene Costello +12 more

Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials

The Lancet(2022)10.1016/s0140-6736(22)01390-3

N/A

0DataRank · unranked

68 citations

Ruitao Lin, Christopher R. Flowers, Shanda Finnigan, Lisa M. Cordes, Yoko Fukuda +7 more

Final results from a phase I trial and expansion cohorts of cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) for metastatic genitourinary tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.3

N/A

0DataRank · unranked

9 citations

Daniel M. Girardi, Scot A. Niglio, Rosa Maria Nadal, Lisa M. Cordes, Seth M. Steinberg +15 more

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2501

N/A

0DataRank · unranked

20 citations

Charalampos S. Floudas, Houssein Abdul Sater, Michell Manu, Elizabeth Lamping, Deneise C Francis +15 more

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

Scientific Reports(2021)10.1038/s41598-021-84960-w

N/A

0DataRank · unranked

3 citations

Barış Türkbey, Billel Gasmi, Keith T. Schmidt, Jonathan D. Strope, Cindy H. Chau +15 more

Evaluating the optimal sequence of immunotherapy and docetaxel in men with metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.130

N/A

0DataRank · unranked

3 citations

Mohammad Atiq, Renee N. Donahue, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +11 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.11.002

N/A

0DataRank · unranked

17 citations

Keith T. Schmidt, Fatima Karzai, Cody J. Peer, Lisa M. Cordes, Cindy H. Chau +8 more

Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.05.005

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Marijo Bilušić, Helen Owens, Lisa M. Cordes, Jennifer L. Marté +5 more

The Dietary Supplement Health And Education Act: are we healthier and better informed after 27 years?

The Lancet Oncology(2021)10.1016/s1470-2045(21)00084-x

N/A

0DataRank · unranked

7 citations

Lisa M. Cordes, William D. Figg, Tristan M. Sissung

Radium 223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.180

N/A

0DataRank · unranked

0 citations

Fatima Karzai, Philip M. Arlen, Clara Chen, Esther Mena, Liza Lindenberg +11 more

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801

N/A

0DataRank · unranked

22 citations

Sofia R. Gameiro, Yohei Ozawa, Karin M. Knudson, Kristin C. Hicks, Claudia Palena +10 more

Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide

European Urology Oncology(2023)10.1016/j.euo.2023.09.010

N/A

0DataRank · unranked

3 citations

Fatima Karzai, Marijo Bilušić, Sheri McMahon, Lisa M. Cordes, Jennifer L. Marté +12 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.368

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Adam G. Sowalsky, Marijo Bilušić, Guinevere Chun, Lisa M. Cordes +9 more

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4607

N/A

0DataRank · unranked

3 citations

Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Rouf Banday +15 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer

The Oncologist(2025)10.1093/oncolo/oyaf429

N/A

0DataRank · unranked

0 citations

Renee N. Donahue, Jennifer L. Marté, Ann Gramza, Marijo Bilušić, Lisa M. Cordes +5 more

Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.207

N/A

0DataRank · unranked

0 citations

Meghali Goswami, Renee N. Donahue, Mohammad Atiq, Fatima Karzai, Marijo Bilušić +13 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Figshare(2023)10.1158/1078-0432.22486556.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Data from Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

(2023)10.1158/1078-0432.c.6529986

N/A

0DataRank · unranked

0 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.c.6532346.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Final results from a phase 1 trial and expansion cohorts of cabozantinib and nivolumab alone or with ipilimumab for advanced/metastatic genitourinary tumors

Research Square(2023)10.21203/rs.3.rs-2924051/v1

N/A

0DataRank · unranked

0 citations

Scot A. Niglio, Rosa Nadal, Andre R. Kydd, Nicholas I. Simon, Lisa Ley +36 more

FDG PET/CT and NaF PET/CT imaging quantification of osseous metastatic lesions in patients with metastatic genitourinary (mGU) cancer and their association with survival outcomes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16573

N/A

0DataRank · unranked

0 citations

Nicholas I. Simon, Elias Chandran, Katherine Lei, Nicholas Peter Verdini, Jeffrey Lin +15 more

Association of 18F-FDG PET characteristics and survival outcomes using whole body tumor analysis in patients (pts) with metastatic genitourinary (GU) malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4600

N/A

0DataRank · unranked

0 citations

Rod Carlo Columbres, Elias Chandran, Scot A. Niglio, Lisa M. Cordes, Lisa Ley +9 more

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16506

N/A

0DataRank · unranked

0 citations

Elias Chandran, Nicholas I. Simon, Lisa Ley, Lisa M. Cordes, Tzu-fang Wang +13 more

A study of prospective monitoring of patients with recurrent prostate cancer using serial PSMA imaging (18F-DCFPyL).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5101

N/A

0DataRank · unranked

0 citations

Liza Lindenberg, Esther Mena Gonzalez, Barış Türkbey, Fatima Karzai, Megan Hausler +8 more

Case Report: Severe Toxicity in an African–American Patient Receiving FOLFOX Carrying Uncommon Allelic Variants in DPYD

Pharmacogenomics(2020)10.2217/pgs-2020-0120

N/A

0DataRank · unranked

8 citations

Lisa M. Cordes, Cody J. Peer, Shruti U. Gandhy, Jason M. Redman, Julius Strauss +2 more

1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1712

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Fatima Karzai, Lisa M. Cordes, Jenn Marte, N. Williams +9 more

Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing and Existing Data Suggest How to Mitigate Toxicity

European Urology Oncology(2024)10.1016/j.euo.2024.06.001

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Ravi A. Madan, Lisa M. Cordes

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer

British Journal of Urology(2020)10.1111/bju.15227

N/A

0DataRank · unranked

13 citations

Fatima Karzai, Munjid Al Harthy, Daniel P. Petrylak, Joseph W. Kim, Philip M. Arlen +22 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

A phase I study of bintrafusp alfa (M7824) and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in adults with metastatic non-prostate genitourinary malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4599

N/A

0DataRank · unranked

4 citations

Daniel M. Girardi, Lisa M. Cordes, Lisa Ley, Marissa Mallek, Olena Sierra Ortiz +15 more

Anaplastic features (AnaF) and DNA-damage repair pathway (DDR) mutations in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.92

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Marijo Bilušić, Lisa M. Cordes, Jennifer L. Marté, Helen Owens +6 more

Lisa M. Cordes

Indexed papers

Top data-sharing exemplar

Papers